Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections

BACKGROUND: Gastric cancer is usually diagnosed in an advanced stage of disease and treatment options are sparse. Trastuzumab was recently approved for metastatic or locally advanced carcinomas arising in the stomach or in the gastroesophageal junction in patients with HER2-positive tumors. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Laboissiere, Renato Santos, Buzelin, Marcelo Araújo, Balabram, Débora, De Brot, Marina, Nunes, Cristiana Buzelin, Rocha, Rafael Malagoli, Cabral, Mônica Maria Demas Álvares, Gobbi, Helenice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632681/
https://www.ncbi.nlm.nih.gov/pubmed/26530403
http://dx.doi.org/10.1186/s12876-015-0384-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632681/
https://www.ncbi.nlm.nih.gov/pubmed/26530403
http://dx.doi.org/10.1186/s12876-015-0384-1

Ejemplares similares